4
Changes in Ownership
Opus Genetics, Inc. Filed Acc 0002042266-25-000003
Director sold 4,000,000 shares at $2.15 ($8,600,000)
From the SEC's structured data for this filing
Trades in this filing
Foundation Fighting Blindness Retinal Degeneration Fund · Director
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-09 | Sale : show line 1 in the form | −4,000,000 | $2.15 | $8,600,000 | 5,492,171 | D |
| Open-market sales · 4,000,000 sh · avg $2.15 · $8,600,000 | ||||||
Loading xslF345X05/primary_doc.xml…